View:
Download DOC
Download PDF
Download XLS
Download XBRL

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): July 19, 2012

 

ALBANY INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)
     
Delaware 1-10026 14-0462060
(State or other jurisdiction
of incorporation)		 (Commission
File Number)

(I.R.S. Employer
Identification No.)

 

216 Airport Drive, Rochester, New Hampshire   03867
(Address of principal executive offices) (Zip Code)
 

Registrant’s telephone number, including area code (518) 445-2200

 

None
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
         

 

 
  

Item 2.02. Results of Operations and Financial Condition

 

Effective with the first quarter of 2012, we merged our Paper Machine Clothing (PMC) and Engineered Fabrics (EF) business segments. The combined segment is called Machine Clothing (MC). The change was made to better align financial reporting with our organizational structure. In the fourth quarter of 2011, we announced the sale of our Albany Door Systems business (ADS) and, beginning with the fourth quarter of 2011, we presented the results of that business as a discontinued operation. Additionally, in the second quarter of 2012, the Company announced the sale of its Primaloft Products® business and, the Company is now presenting the results of that business as a discontinued operation.

 

This Form 8-K provides tables that illustrate the effects of the foregoing changes on previously-issued financial statements.

 

Concurrent with this Form 8-K, the Company is filing a Form 8-K/A with pro forma exhibits as required pursuant to Item 9.01(b) and Article 11 of Regulation S-X as the result of the sale of the Primaloft Products® business. Whereas the Company often provides commentary and forward-looking information by comparing to amounts reported in previous periods, the Exhibits provided in this Form 8-K are intended to provide investors with historical financial data beyond the requirements of Item 9.01(b) and Article 11 of Regulation S-X.

 

Additionally, in previously filed quarterly and annual reports, the Company has presented information about earnings before interest, taxes, depreciation and amortization (EBITDA), and EBITDA excluding the effects of restructuring costs, foreign-currency revaluation effects, and certain other gains and losses (Adjusted EBITDA). Exhibit 99.5 sets forth EBITDA and Adjusted EBITDA, revised to reflect the foregoing changes, for each reportable segment, as well as for the total continuing operations of the Company.

 

The attached schedules also reflect the reclassification of amounts previously reported in the Income Statement as Earnings from Associated Companies into Other income/expense.

This Form 8-K contains certain items, such as earnings before interest, taxes, depreciation and amortization (EBITDA), EBITDA excluding restructuring charges,  currency effects, building sale gains, pension settlement charges and gains related to the early retirement of debt (Adjusted EBTIDA) that could be considered non-GAAP financial measures. Such items are provided because management believes that, when presented together with the GAAP items to which they relate, they provide additional useful information to investors regarding the Company’s operational performance. An understanding of the impact in a particular quarter of specific restructuring costs, or other gains and losses, on operating income or EBITDA can give management and investors additional insight into quarterly performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

 

99.1Effect of changes for the second quarter of 2011.

 

99.2Effect of changes for the third quarter of 2011.

  

99.3Effect of changes for the fourth quarter of 2011.

 

99.4Effect of changes on the Income Statement for the second quarter of 2011 (000’s, except per share amounts).

  

99.5Effect of changes on the Income Statement for the third quarter of 2011 (000’s, except per share amounts).

  

99.6Effect of changes on the Income Statement for the fourth quarter of 2011 (000’s, except per share amounts).

 

99.7Schedule showing the effect on Item 6 of the 2011 Form 10-K, Selected Financial Data (000’s, except per share amounts).

 

99.8Schedules showing EBITDA and Adjusted EBITDA by reportable segment for the first quarter of 2012, quarterly periods of 2011, and full year periods 2011, 2010 and 2009 (000’s, except per share amounts).

 

 
  

Signature

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

  ALBANY INTERNATIONAL CORP.
   
   
  By: /s/ John B. Cozzolino
   
  Name: John B. Cozzolino
  Title:  Chief Financial Officer and Treasurer
  (Principal Financial Officer)

 

 

Date:    July 19, 2012

 

 
  

 

EXHIBIT INDEX

 

Exhibit No. Description

 

99.1Effect of changes for the second quarter of 2011.
99.2Effect of changes for the third quarter of 2011.

99.3Effect of changes for the fourth quarter of 2011.
99.4Effect of changes on the Income Statement for the second quarter of 2011 (000’s, except per share amounts).
99.5Effect of changes on the Income Statement for the third quarter of 2011 (000’s, except per share amounts).
99.6 Effect of changes on the Income Statement for the fourth quarter of 2011 (000’s, except per share amounts).
99.7 Schedule showing the effect on Item 6 of the 2011 Form 10-K, Selected Financial Data (000’s, except per share amounts).
99.8 Schedules showing EBITDA and Adjusted EBITDA by reportable segment for the first quarter of 2012, quarterly periods of 2011, and full year periods 2011, 2010 and 2009 (000’s, except per share amounts).
 

99.1   Effect of changes for the second quarter of 2011.

 

  USD 000's  Q2 2011  Reclassify ADS  Merge PMC  Reclassify Primaloft  Q2 2011 in  Six months ended
     As reported  to Discontinued  and EF  to Discontinued  2012 format  June 30, 2011
Net sales PMC  $158,577        $(158,577)       $-   $- 
  Machine Clothing   -         179,177         179,177    367,659 
  Doors   45,393    (45,393)        -    -    - 
  EF   20,600         (20,600)        -    - 
  Composites   10,504                   10,504    21,976 
  Primaloft   8,941              (8,941)   -    - 
  Total  $244,015   $(45,393)  $-   $(8,941)  $189,681   $389,635 
                                 
                                 
Gross Margin PMC  $67,373        $(67,373)       $-   $- 
  Machine Clothing   -         74,953         74,953    161,490 
  Doors   16,174    (16,174)        -    -    - 
  EF   7,580         (7,580)        -    - 
  Composites   155                   155    136 
  Primaloft   4,786              (4,786)   -    - 
  Non Segment   (1,168)                  (1,168)   (2,498)
  Total  $94,900   $(16,174)  $-   $(4,786)  $73,940   $159,128 
                                 
                                 
Selling, technical PMC  $32,016   $-   $(32,016)  $-   $-   $- 
general and research Machine Clothing   -         36,672         36,672    72,905 
expenses Doors   11,760    (11,760)        -    -    - 
EF   4,656         (4,656)        -    - 
  Composites   1,255                   1,255    2,266 
  Primaloft   1,621              (1,621)   -    - 
  Research   7,212                   7,212    14,377 
  Non Segment   15,206    (576)        (40)   14,590    30,261 
  Total  $73,726   $(12,336)  $-   $(1,661)  $59,729   $119,809 
                                 
                                 
                                 
Restructuring PMC  $448        $(448)       $-   $- 
included in segment Machine Clothing             572         572    605 
operating income Doors   361    (361)        -    -    - 
EF   124         (124)        -    - 
Composites   44                   44    57 
  Primaloft   -              -    -    - 
  Research   -                   -    - 
  Non Segment   1,115                   1,115    1,103 
  Total  $2,092   $(361)  $-   $-   $1,731   $1,765 
                                 
                                 
                                 
                                 
Operating Income PMC  $34,909   $-   $(34,909)  $-   $-   $- 
Machine Clothing   -    -    37,709    -    37,709    87,980 
  Doors   4,053    (4,053)   -    -    -    - 
  EF   2,800    -    (2,800)   -    -    - 
  Composites   (1,144)   -    -    -    (1,144)   (2,187)
  Primaloft   3,165    -    -    (3,165)   -    - 
  Research   (7,212)   -    -    -    (7,212)   (14,377)
  Non Segment   (17,489)   576    -    40    (16,873)   (33,862)
  Total  $19,082   $(3,477)  $-   $(3,125)  $12,480   $37,554 

 

99.2   Effect of changes for the third quarter of 2011.

 

  USD 000's  Q3 2011  Reclassify ADS  Merge PMC  Reclassify Primaloft  Q3 2011 in  Nine months ended
     As reported  to Discontinued  and EF  to Discontinued  2012 format  September 30, 2011
Net sales PMC  $168,067        $(168,067)       $-   $- 
  Machine Clothing   -         188,334         188,334    555,993 
  Doors   43,276    (43,276)        -    -    - 
  EF   20,267         (20,267)        -    - 
  Composites   11,918                   11,918    33,894 
  Primaloft   6,484              (6,484)   -    - 
  Total  $250,012   $(43,276)  $-   $(6,484)  $200,252   $589,887 
                                 
                                 
Gross Margin PMC  $72,612        $(72,612)       $-   $- 
  Machine Clothing   -         79,338         79,338    240,828 
  Doors   14,470    (14,470)        -    -    - 
  EF   6,726         (6,726)        -    - 
  Composites   (300)                  (300)   (164)
  Primaloft   3,226              (3,226)   -    - 
  Non Segment   (976)                  (976)   (3,474)
  Total  $95,758   $(14,470)  $-   $(3,226)  $78,062   $237,190 
                                 
                                 
Selling, technical PMC  $24,860   $-   $(24,860)  $-   $-   $- 
general and research Machine Clothing   -         27,861         27,861    100,766 
expenses Doors   10,782    (10,782)        -    -    - 
  EF   3,001         (3,001)        -    - 
  Composites   1,134                   1,134    3,400 
  Primaloft   1,992              (1,992)   -    - 
  Research   6,400                   6,400    20,777 
  Non Segment   14,356    (1,109)        (29)   13,218    43,479 
  Total  $62,525   $(11,891)  $-   $(2,021)  $48,613   $168,422 
                                 
                                 
                                 
Restructuring PMC  $440        $(440)       $-   $- 
included in segment Machine Clothing              2,610         2,610    3,215 
operating income Doors   14   (14)        -    -    - 
  EF   2,170         (2,170)        -    - 
  Composites   -                   -    57 
  Primaloft   -              -    -    - 
  Research   -                   -    - 
  Non Segment   81                   81    1,184 
  Total  $2,705   $(14)  $-   $-   $2,691   $4,456 
                                 
                                 
                                 
                                 
Operating Income PMC  $47,312   $-   $(47,312)  $-   $-   $- 
  Machine Clothing   -    -    48,867    -    48,867    136,847 
  Doors   3,674    (3,674)   -    -    -    - 
  EF   1,555    -    (1,555)   -    -    - 
  Composites   (1,434)   -    -    -    (1,434)   (3,621)
  Primaloft   1,234    -    -    (1,234)   -    - 
  Research   (6,400)   -    -    -    (6,400)   (20,777)
  Non Segment   (15,413)   1,109    -    29    (14,275)   (48,137)
  Total  $30,528   $(2,565)  $-   $(1,205)  $26,758   $64,312 

 

99.3   Effect of changes for the fourth quarter of 2011.

 

  USD 000's  Q4 2011  Merge PMC  Reclassify Primaloft  Q4 2011 in  Year ended
     As reported  and EF  to Discontinued  2012 format  December 31, 2011
Net sales PMC  $163,029   $(163,029)       $-   $- 
  Machine Clothing   -    183,218         183,218    739,211 
  EF   20,189    (20,189)        -    - 
  Composites   14,182              14,182    48,076 
  Primaloft   5,216         (5,216)   -    - 
  Total  $202,616   $-   $(5,216)  $197,400   $787,287 
                            
                            
Gross Margin PMC  $70,151   $(70,151)       $-   $- 
  Machine Clothing   -    77,156         77,156    317,984 
  EF   7,005    (7,005)        -    - 
  Composites   671              671    507 
  Primaloft   3,126         (3,126)   -    - 
  Non Segment   (851)             (851)   (4,325)
  Total  $80,102   $-   $(3,126)  $76,976   $314,166 
                            
                            
Selling, technical PMC  $30,735   $(30,735)  $-   $-   $- 
general and research Machine Clothing   -    34,780         34,780    135,546 
expenses EF   4,045    (4,045)        -    - 
  Composites   1,254              1,254    4,654 
  Primaloft   896         (896)   -    - 
  Research   8,230              8,230    29,007 
  Non Segment   17,557         (1)   17,556    61,035 
  Total  $62,717   $-   $(897)  $61,820   $230,242 
                            
                            
                            
Restructuring PMC  $2,339   $(2,339)       $-   $- 
included in segment Machine Clothing   -    2,465         2,465    5,680 
  EF   126    (126)        -    - 
  Composites   -              -    57 
  Primaloft   -         -    -    - 
  Research   -              -    - 
  Non Segment   2,396              2,396    3,580 
  Total  $4,861   $-   $-   $4,861   $9,317 
                            
                            
                            
                            
Operating Income PMC  $37,077   $(37,077)  $-   $-   $- 
  Machine Clothing   -    39,911    -    39,911    176,758 
  EF   2,834    (2,834)   -    -    - 
  Composites   (583)   -    -    (583)   (4,204)
  Primaloft   2,230    -    (2,230)   -    - 
  Research   (8,230)   -    -    (8,230)   (29,007)
  Non Segment   (20,804)   -    1    (20,803)   (68,940)
  Total  $12,524   $-   $(2,229)  $10,295   $74,607 

99.4   Effect of changes on the Income Statement for the second quarter of 2011 (000's, except per share amounts).

 

  As reported               
  Three months ended  Reclassify ADS  Reclassify Primaloft     Q2 2011  Six months ended
  June 30,  to discontinued  to discontinued  Other  reported in  June 30, 2011
  2011  operations  operations  reclassifications  2012 format  in 2012 format
                              
Net sales $244,015   ($45,393)  ($8,941)       $189,681   $389,635 
Cost of goods sold  149,115    (29,219)   (4,155)        115,741    230,507 
                              
Gross profit  94,900    (16,174)   (4,786)   -    73,940    159,128 
  Selling, general, and administrative expenses  58,359    (11,519)   (1,437)        45,403    91,370 
  Technical, product engineering, and research expenses  15,367    (817)   (224)        14,326    28,439 
  Restructuring and other, net  2,092    (361)   -         1,731    1,765 
  Pension settlement expense  -    -    -         -    - 
                              
Operating income  19,082    (3,477)   (3,125)   -    12,480    37,554 
  Interest expense, net  4,786    -    -         4,786    9,562 
  Other expense, net  55    (49)   -    1    7    4,820 
                              
Income before income taxes  14,241    (3,428)   (3,125)   (1)   7,687    23,172 
  Income tax expense/(benefit)  5,359    (1,039)   (1,181)        3,139    6,406 
                              
Income from continuing operations before earnings of associated companies  8,882    (2,389)   (1,944)   (1)   4,548    16,766 
Equity in losses from associated companies  120    (119)   -    (1)   -    - 
                              
Income from continuing operations  8,762    (2,270)   (1,944)   -    4,548    16,766 
                              
  Income from operations of discontinued business       3,309    3,125         6,434    12,991 
  Gain on sale of discontinued business  -    -    -         -    0 
  Income tax expense on discontinued operations  -    1,039    1,181         2,220    4,262 
Income from discontinued operations  -    2,270    1,944         4,214    8,729 
Net income $8,762   $-   $-   $-   $8,762   $25,495 
                              
Earnings per share - Basic                             
(Loss)/income from continuing operations $0.28                  $0.15   $0.54 
Discontinued operations  0.00                   0.13    0.28 
Net (loss)/income $0.28                  $0.28   $0.82 
                              
Earnings per share - Diluted                             
(Loss)/income from continuing operations $0.28                  $0.14   $0.53 
Discontinued operations  0.00                   0.14    0.28 
Net (loss)/income $0.28                  $0.28   $0.81 
                              
Shares used in computing earnings per share:                             
  Basic  31,263                   31,263    31,243 
  Diluted  31,489                   31,489    31,455 

99.5   Effect of changes on the Income Statement for the third quarter of 2011 (000's, except per share amounts).

 

  As reported               
  Three months ended  Reclassify ADS  Reclassify Primaloft     Q3 2011  Nine months ended
  September 30,  to discontinued  to discontinued  Other  reported in  September 30, 2011
  2011  operations  operations  reclassifications  2012 format  in 2012 format
                              
Net sales $250,012   ($43,276)  ($6,484)       $200,252   $589,887 
Cost of goods sold  154,254    (28,806)   (3,258)        122,190    352,697 
                              
Gross profit  95,758    (14,470)   (3,226)   -    78,062    237,190 
  Selling, general, and administrative expenses  48,840    (11,143)   (1,750)        35,947    127,317 
  Technical, product engineering, and research expenses  13,685    (748)   (271)        12,666    41,105 
  Restructuring and other, net  2,705    (14)   -         2,691    4,456 
  Pension settlement expense  -    -    -         -    - 
                              
Operating income  30,528    (2,565)   (1,205)   -    26,758    64,312 
  Interest expense, net  4,377    -    -         4,377    13,939 
  Other expense, net  374    (323)   -    (60)   (9)   4,811 
                              
Income before income taxes  25,777    (2,242)   (1,205)   60    22,390    45,562 
  Income tax expense/(benefit)  9,032    (679)   (455)        7,897    14,303 
                              
Income from continuing operations before earnings of associated companies  16,745    (1,563)   (750)   60    14,493    31,259 
Equity in losses from associated companies  71    (131)   -    60    -    - 
                              
Income from continuing operations  16,674    (1,432)   (750)   -    14,493    31,259 
                              
  Income from operations of discontinued business       2,111    1,205         3,316    16,307 
  Gain on sale of discontinued business  -    -    -         -    0 
  Income tax expense on discontinued operations  -    679    455         1,135    5,397 
Income from discontinued operations  -    1,432    750         2,181    10,910 
Net income $16,674   $-   $-   $-   $16,674   $42,169 
                              
Earnings per share - Basic                             
(Loss)/income from continuing operations $0.53                  0.46   $1.00 
Discontinued operations  0.00                   0.07    0.35 
Net (loss)/income $0.53                  0.53   $1.35 
                              
Earnings per share - Diluted                             
(Loss)/income from continuing operations $0.53                  0.46   $0.99 
Discontinued operations  0.00                  0.07   $0.35 
Net (loss)/income $0.53                  0.53   $1.34 
                              
Shares used in computing earnings per share:                             
  Basic  31,278                   31,278    31,255 
  Diluted  31,462                   31,462    31,476 

99.6   Effect of changes on the Income Statement for the fourth quarter of 2011 (000’s, except per share amounts).

   As reported
 Three months ended
December 31,
2011		  Reclassify Primaloft
to discontinued
operations		  Other
reclassifications		  Q4 2011
reported in
2012 format		  Year ended
December 31, 2011
in 2012 format
                     
Net sales  $202,617   ($5,217)      $197,400   $787,287 
Cost of goods sold  122,515   (2,091)      120,424   473,121 
                     
Gross profit  80,102   (3,126)  -   76,976   314,166 
  Selling, general, and administrative expenses  47,791   (713)      47,078   174,395 
  Technical, product engineering, and research expenses  14,925   (184)      14,741   55,846 
  Restructuring and other, net  4,861   -       4,861   9,317 
  Pension settlement expense  -   -       -   - 
                     
Operating income  12,525   (2,229)  -   10,296   74,608 
  Interest expense, net  4,182   -       4,182   18,121 
  Other (income)/expense, net  (2,163)  -   (9)  (2,172)  2,639 
                     
Income before income taxes  10,506   (2,229)  9   8,286   53,848 
  Income tax expense/(benefit)  19,118   (840)      18,278   32,582 
                     
Income from continuing operations before earnings of associated companies  (8,612)  (1,389)  9   (9,992)  21,266 
Equity in (earnings)/losses from associated companies  (9)  -   9   -   - 
                     
Income from continuing operations  (8,603)  (1,389)  -   (9,992)  21,266 
                     
  Income from operations of discontinued business  5,565   2,229       7,794   24,101 
  Gain on sale of discontinued business  -   -       -   0 
  Income tax expense on discontinued operations  4,193   840       5,033   10,429 
Income from discontinued operations  1,372   1,389       2,761   13,672 
Net income  ($7,231)  $        -   $        -   ($7,231)  $34,938 
                     
Earnings per share - Basic                    
(Loss)/income from continuing operations  ($0.28)          ($0.32)  $0.68 
Discontinued operations  0.05           0.09   0.44 
Net (loss)/income  ($0.23)          ($0.23)  $1.12 
                     
Earnings per share - Diluted                    
(Loss)/income from continuing operations  ($0.28)          ($0.32)  $0.67 
Discontinued operations  0.05           $0.09   $0.44 
Net (loss)/income  ($0.23)          ($0.23)  $1.11 
                     
Shares used in computing earnings per share:                    
 Basic  31,283           31,283   31,262 
 Diluted  31,283           31,283   31,510 

 

  

99.7   Schedule showing the effect on Item 6 of the 2011 Form 10-K, Selected Financial Data (000’s, except per share amounts).

Selected financial data - as previously reported under Item 6 of 2011 Form 10-K

(in thousands, except per share amounts)   2011  2010  2009  2008
Summary of Operations                     
Net sales  $814,696   $765,769   $737,621   $897,169 
Cost of goods sold   485,735    471,006    484,335    595,910 
Restructuring and other   9,317    3,747    68,174    37,708 
Goodwill and intangible impairment charge   -    -    -    73,316 
Operating income/(loss)   83,073    71,285    (36,126)   (81,805)
Interest expense, net   18,121    17,240    20,627    24,253 
Income/(loss) from continuing operations    26,534    31,476    (21,461)   (91,936)
(Loss)/income from discontinued operations   8,404    6,160    (11,997)   14,490 
Net income/(loss)   34,938    37,636    (33,458)   (77,446)
Basic income/(loss) from continuing operations per share   0.85    1.01    (0.70)   (3.09)
Basic net income/(loss) per share    1.12    1.21    (1.09)   (2.60)
Diluted net income/(loss) per share   1.11    1.21    (1.09)   (2.60)
Dividends declared per share    0.51    0.48    0.48    0.47 
Weighted average number of shares outstanding - basic    31,262    31,072    30,612    29,786 
Capital expenditures, including software   27,504    31,048    41,863    139,815 
                     
Financial position                     
Cash   $118,909   $117,925   $94,139   $103,998 
Property, plant and equipment, net    439,516    481,952    507,440    529,423 
Total assets   1,230,928    1,278,293    1,345,149    1,404,118 
Current liabilities   170,711    165,856    188,164    210,177 
Long-term debt    373,125    423,634    483,894    530,176 
Total noncurrent liabilities   644,367    686,178    734,372    775,352 
Total liabilities   815,078    852,034    922,536    985,529 
Shareholders’ equity   415,850    426,259    422,613    418,589 

Adjustments to selected financial data

(in thousands, except per share amounts)   2011  2010  2009  2008
Summary of Operations                     
Net sales  $(27,409)  $(22,882)  $(18,992)  $(21,418)
Cost of goods sold   (12,614)   (10,092)   (10,139)   (11,867)
Restructuring and other   -    -    (61)   (182)
Operating income   (8,465)   (6,576)   (3,594)   (3,092)
Income from continuing operations    (5,268)   (4,053)   (2,071)   (1,809)
Income from discontinued operations   5,268    4,053    2,071    1,809 
Basic income/(loss) from continuing operations per share   (0.17)   (0.13)   (0.07)   (0.06)
Capital expenditures, including software   (76)   (91)   (36)   (25)
Property, plant and equipment, net    (563)   (1,241)   (1,607)   (2,810)

Selected financial data - as adjusted to reclassify Primaloft Products to discontinued operations

(in thousands, except per share amounts)   2011  2010  2009  2008
Summary of Operations                     
Net sales  $787,287   $742,887   $718,629   $875,751 
Cost of goods sold   473,121    460,914    474,196    584,043 
Restructuring and other   9,317    3,747    68,113    37,526 
Goodwill and intangible impairment charge   -    -    -    73,316 
Operating income/(loss)   74,608    64,709    (39,720)   (84,897)
Interest expense, net   18,121    17,240    20,627    24,253 
Income/(loss) from continuing operations    21,266    27,423    (23,532)   (93,745)
(Loss)/income from discontinued operations   13,672    10,213    (9,926)   16,299 
Net income/(loss)   34,938    37,636    (33,458)   (77,446)
Basic income/(loss) from continuing operations per share   0.68    0.88    (0.77)   (3.15)
Basic net income/(loss) per share    1.12    1.21    (1.09)   (2.60)
Diluted net income/(loss) per share   1.11    1.21    (1.09)   (2.60)
Dividends declared per share    0.51    0.48    0.48    0.47 
Weighted average number of shares outstanding - basic    31,262    31,072    30,612    29,786 
Capital expenditures, including software   27,428    30,957    41,827    139,790 
                     
Financial position                     
Cash   $118,909   $117,925   $94,139   $103,998 
Property, plant and equipment, net    438,953    480,711    505,833    526,613 
Total assets   1,230,928    1,278,293    1,345,149    1,404,118 
Current liabilities   170,711    165,856    188,164    210,177 
Long-term debt    373,125    423,634    483,894    530,176 
Total noncurrent liabilities   644,367    686,178    734,372    775,352 
Total liabilities   815,078    852,034    922,536    985,529 
Shareholders’ equity   415,850    426,259    422,613    418,589 

99.8   Schedules showing EBITDA and Adjusted EBITDA by reportable segment for the first quarter of 2012, quarterly periods of 2011, and full year periods 2011, 2010 and 2009 (000’s, except per share amounts).

Three months ended March 31, 2012  Machine     Research and  Total
   Clothing  AEC  Unallocated  Company
Income from continuing operations  $30,845   $29   $(31,003)  $(129)
Interest expense, net   -    -    4,644    4,644 
Income tax expense/(benefit)   -    -    (9,972)   (9,972)
Depreciation and amortization   12,053    1,405    2,569    16,027 
EBITDA from continuing operations   42,898    1,434    (33,762)   10,570 
Restructuring, net   673    -    (415)   258 
Foreign currency revaluation losses/(gains)   1,766    -    3,834    5,600 
Other charges/(credits) (A)   -    -    9,175    9,175 
Adjusted EBITDA from continuing operations  $45,337   $1,434   $(21,168)  $25,603 

(A) The Company incurred a charge of $9.2 million in connection with the settlement of a pension plan.

Three months ended March 31, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $50,271   $(1,043)  $(37,010)  $12,218 
Interest expense, net   -    -    4,776    4,776 
Income tax expense/(benefit)   -    -    3,267    3,267 
Depreciation and amortization   12,019    1,196    2,408    15,623 
EBITDA from continuing operations   62,290    153    (26,559)   35,884 
Restructuring, net   33    13   (12)   34 
Foreign currency revaluation losses/(gains)   1,968    1    3,871    5,840 
Other charges/(credits) (B)   (400)   -    -    (400)
Adjusted EBITDA from continuing operations  $63,891   $167   $(22,700)  $41,358 

(B) The Company recorded a gain of $0.4 million in connection with the sale of a former manufacturing facility.

Three months ended June 30, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $37,709   $(1,144)  $(32,017)  $4,548 
Interest expense, net   -    -    4,786    4,786 
Income tax expense/(benefit)   -    -    3,139    3,139 
Depreciation and amortization   12,152    1,203    2,620    15,975 
EBITDA from continuing operations   49,861    59    (21,472)   28,448 
Restructuring, net   572    44    1,115    1,731 
Foreign currency revaluation losses/(gains)   1,982    1    (490)   1,493 
Other charges/(credits) (C )   (608)   -    -    (608)
Adjusted EBITDA from continuing operations  $51,807   $104   $(20,847)  $31,064 

(C) The Company recorded a gain of $0.6 million in connection with the sale of a former manufacturing facility.

Six months ended June 30, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $87,980   $(2,187)  $(69,027)  $16,766 
Interest expense, net   -    -    9,562    9,562 
Income tax expense/(benefit)   -    -    6,406    6,406 
Depreciation and amortization   24,171    2,399    5,028    31,598 
EBITDA from continuing operations   112,151    212    (48,031)   64,332 
Restructuring, net   605    57    1,103    1,765 
Foreign currency revaluation losses/(gains)   3,950    2    3,381    7,333 
Other charges/(credits)  (D)   (1,008)   -    -    (1,008)
Adjusted EBITDA from continuing operations  $115,698   $271   $(43,547)  $72,422 

(D) The Company recorded gains of $1.0 million in connection with the sale of a former manufacturing facilities.

Three months ended September 30, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $48,867   $(1,434)  $(32,940)  $14,493 
Interest expense, net   -    -    4,377    4,377 
Income tax expense/(benefit)   -    -    7,897    7,897 
Depreciation and amortization   12,049    1,241    2,642    15,932 
EBITDA from continuing operations   60,916    (193)   (18,024)   42,699 
Restructuring, net   2,610    -    81    2,691 
Foreign currency revaluation losses/(gains)   (5,775)   -    (623)   (6,398)
Other charges/(credits)   -    -    -    - 
Adjusted EBITDA from continuing operations  $57,751   $(193)  $(18,566)  $38,992 

Nine months ended September 30, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $136,847   $(3,621)  $(101,967)  $31,259 
Interest expense, net   -    -    13,939    13,939 
Income tax expense/(benefit)   -    -    14,303    14,303 
Depreciation and amortization   36,220    3,640    7,670    47,530 
EBITDA from continuing operations   173,067    19    (66,055)   107,031 
Restructuring, net   3,215    57    1,184    4,456 
Foreign currency revaluation losses/(gains)   (1,825)   2    2,758    935 
Other charges/(credits)  (D)   (1,008)   -    -    (1,008)
Adjusted EBITDA from continuing operations  $173,449   $78   $(62,113)  $111,414 

(D) The Company recorded gains of $1.0 million in connection with the sale of a former manufacturing facilities.

Three months ended December 31, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $39,911   $(583)  $(49,320)  $(9,992)
Interest expense, net   -    -    4,182    4,182 
Income tax expense/(benefit)   -    -    18,278    18,278 
Depreciation and amortization   12,039    1,319    2,667    16,025 
EBITDA from continuing operations   51,950    736    (24,193)   28,493 
Restructuring, net   2,465    -    2,396    4,861 
Foreign currency revaluation losses/(gains)   (860)   (1)   (2,736)   (3,597)
Other charges/(credits)   -    -    -    - 
Adjusted EBITDA from continuing operations  $53,555   $735   $(24,533)  $29,757 

Year ended December 31, 2011  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $176,758   $(4,204)  $(151,288)  $21,266 
Interest expense, net   -    -    18,121    18,121 
Income tax expense/(benefit)   -    -    32,582    32,582 
Depreciation and amortization   48,259    4,959    10,337    63,555 
EBITDA from continuing operations   225,017    755    (90,248)   135,524 
Restructuring, net   5,680    57    3,580    9,317 
Foreign currency revaluation losses/(gains)   (2,685)   1    22    (2,662)
Other charges/(credits)  (D)   (1,008)   -    -    (1,008)
Adjusted EBITDA from continuing operations  $227,004   $813   $(86,646)  $141,171 

(D) The Company recorded gains of $1.0 million in connection with the sale of a former manufacturing facilities.

Year ended December 31, 2010  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $165,662   $(9,176)  $(129,063)  $27,423 
Interest expense, net   -    -    17,240    17,240 
Income tax expense/(benefit)   -    -    21,022    21,022 
Depreciation and amortization   46,982    4,253    9,014    60,249 
EBITDA from continuing operations   212,644    (4,923)   (81,787)   125,934 
Restructuring, net   4,762    930    (1,945)   3,747 
Foreign currency revaluation losses/(gains)   (397)   7    (4,552)   (4,942)
Other charges/(credits) (E)   (9,400)   -    -    (9,400)
Adjusted EBITDA from continuing operations  $207,609   $(3,986)  $(88,284)  $115,339 

(E) The Company recorded a gain of $0.6 million in connection with the sale of a former manufacturing facility.

Year ended December 31, 2009  Machine     Research and  Total
000’s  Clothing  AEC  Unallocated  Company
Income from continuing operations  $45,671   $(6,653)  $(62,550)  $(23,532)
Interest expense, net   -    -    20,627    20,627 
Income tax expense/(benefit)   -    -    12,917    12,917 
Depreciation and amortization   56,156    3,200    7,928    67,284 
EBITDA from continuing operations   101,827    (3,453)   (21,078)   77,296 
Restructuring, net   71,252    291    (3,430)   68,113 
Foreign currency revaluation losses/(gains)   2,710    4    (2,203)   511 
Other charges/(credits) (F)   -    -    (51,959)   (51,959)
Adjusted EBITDA from continuing operations  $175,789   $(3,158)  $(78,670)  $93,961 

(F) The Company recorded gains of $52.0 million related to early retirement of debt.